Mobix Labs is trading 5.28% down at $1.17, underperforming a broadly firmer U.S. market on August 21, 2026, amid investor concerns over its delayed second-quarter 10-Q.
- An August 14 Form 12b-25 filing attributed the delay to late financing transactions and accounting-department turnover.
- Preliminary revenue was approximately $0.8 million versus $2.4 million a year earlier; net loss was approximately $16.8 million versus $8.3 million.
- The company reported continued substantial doubt about its ability to continue as a going concern.